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Abstract
Background: Real-time reverse transcriptase quantitative polymerase chain reaction (real-time RT-
qPCR) is the most accurate measure of gene expression in biological systems. The comparison of different
samples requires the transformation of data through a process called normalisation. Reference or
housekeeping genes are candidate genes which are selected on the basis of constitutive expression across
samples, and allow the quantification of changes in gene expression. At present, no reference gene has
been identified for any organism which is universally optimal for use across different tissue types or disease
situations. We used microarray data to identify new reference genes generated from total RNA isolated
from normal and osteoarthritic canine articular tissues (bone, ligament, cartilage, synovium and fat). RT-
qPCR assays were designed and applied to each different articular tissue. Reference gene expression
stability and ranking was compared using three different mathematical algorithms.
Results: Twelve new potential reference genes were identified from microarray data. One gene
(mitochondrial ribosomal protein S7 [MRPS7]) was stably expressed in all five of the articular tissues
evaluated. One gene HIRA interacting protein 5 isoform 2 [HIRP5]) was stably expressed in four of the
tissues evaluated.  A commonly used reference gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was not stably expressed in any of the tissues evaluated. Most consistent agreement between rank
ordering of reference genes was observed between Bestkeeper© and geNorm, although each method
tended to agree on the identity of the most stably expressed genes and the least stably expressed genes
for each tissue. New reference genes identified using microarray data normalised in a conventional manner
were more stable than those identified by microarray data normalised by using a real-time RT-qPCR
methodology.
Conclusion: Microarray data normalised by a conventional manner can be filtered using a simple stepwise
procedure to identify new reference genes, some of which will demonstrate good measures of stability.
Mitochondrial ribosomal protein S7 is a new reference gene worthy of investigation in other canine tissues
and diseases. Different methods of reference gene stability assessment will generally agree on the most
and least stably expressed genes, when co-regulation is not present.
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The quantification of gene expression allows the mecha-
nism organising biological activity to be determined. At
present, real-time RT-qPCR provides the most accurate
and specific measure of gene expression, with an unsur-
passed dynamic range and a high level of reproducibility.
A number of variables will contribute to the variability of
gene expression measurements, such as the number and
type of cells in the tissue evaluated, the method and effi-
ciency of mRNA extraction, mRNA handling techniques
[1], mRNA integrity [2,3], method of reverse transcription
[4] and analytical detection chemistry method [1]. These
inter-sample differences are addressed through the proc-
ess of normalisation [5], whereby the expression of an
individual gene within a sample is related to that of a cal-
ibrating gene known as a reference, control or "house-
keeping" gene. Ideally, a reference gene is expressed at a
consistent and repeatable quantity across all samples
being compared, so that relative differences in gene
expression can be measured with confidence. Commonly
used reference genes such as beta-2-microglobulin (B2M),
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
and beta actin (ACTB), are not constantly expressed across
all tissue types and disease states [6,7]. Thus it is widely
accepted that the selection of reference genes should be
established through the validation of expression stability
in the tissue or cells of interest, before use.
A number of statistical algorithms exist for the optimisa-
tion of reference gene selection, such as geNorm [6], Glo-
bal Pattern Recognition [8], Bestkeeper©[9], equivalence
tests [10] and NormFinder [11]. In each case, mathemati-
cal evaluation of expression data allows the ordering of
candidate reference genes, on the basis of the relative
expression stabilities. At present, no gold standard exists
for the selection of reference genes, and although meth-
ods have been compared with similar results in some
reports [12-14] but not in others [11], the optimal
method for selections remains unknown.
The identification of new reference genes from microarray
data, within a particular tissue type, has been demon-
strated to provide more "stable" reference genes than
those conventionally used [11,14-16], as determined
using stability algorithms. Microarray data can be strati-
fied on the basis of fold changes in expression [14], the
variance of expression [11,16] or integrative correlations
[15]. Candidate genes can then be selected from stratified
data, and frequently demonstrate expression stabilities
greater than conventionally used reference genes
[11,14,15]. However microarray data has yet to identify a
new reference gene which shows consistent stability
across multiple tissue or cell types, and/or disease situa-
tions. Therefore a ubiquitous reference gene suitable for
normalisation of gene expression of all experiments prob-
ably does not exist, but the identification of new reference
genes to improve in reference gene stability is important
to reduce error in RT-qPCR experiments.
In this study, we identified candidate reference genes from
microarray expression profiling data generated from the
evaluation of two different canine articular tissues (carti-
lage and cranial cruciate ligament). The relative stability of
expression of each reference gene in normal and osteoar-
thritic canine articular tissues was determined from RT-
qPCR reactions using statistical algorithmic packages. The
stability of the new reference genes were compared
between tissues, and related to a commonly used refer-
ence gene(GAPDH).
Results
New reference genes
Identities and putative functions of each of the new refer-
ence genes are listed in Table 1. Although the genes
selected did not localise to common pathways or func-
tions, two of the genes coded for mitochondrial ribos-
omal proteins. The metrics of the candidate reference gene
stability are presented in Table 2.
Articular cartilage
All methods of stability analysis agreed in finding the new
genes MRPS7 and MRPS25 to be stably expressed. Like-
wise, C7orf28B and NCK2 were determined to be the least
stably expressed genes by both geNorm (Figure 2B) and
NormFinder (Figure 2A). GAPDH was identified as the 4th
most stably expressed gene by both geNorm and Best-
keeper©, and the 8th most stably expressed gene by
NormFinder.
Infrapatella fat pad
All three methods of reference gene analysis agreed on the
most stably expressed reference genes, which were
C7orf28B, MRPS7 and MAPK6. GeNorm (Figure 2B) and
NormFinder (Figure 2A) agreed that the least stably
expressed gene was NCK2. GAPDH was identified as the
9th most stably expressed gene by NormFinder, the 7th
most stably expressed gene by geNorm, and the 5th most
stably expressed gene by Bestkeeper©.
Cranial cruciate ligament
Methods did not agree on the most stably expressed genes,
although all methods agreed on the five most stably
expressed genes (albeit, not their order); ATIC, MRPS7,
C7orf28B, ORMDL2 and HIRP5. MRPS25 was the least sta-
bly expressed gene as determined by both NormFinder
(Figure 2A) and geNorm (Figure 2B). GAPDH was identi-
fied as the 7th most stably expressed gene by NormFinder,
the 9th most stably expressed gene by geNorm, and the 8th
most stably expressed gene by Bestkeeper©.Page 2 of 10
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Although Bestkeeper© and NormFinder agreed on the six
most stably expressed genes (MRPS25, ATIC, HIRP5, TKT,
MRPS7, PTDSS1), and NCK2 was determined to be the
least stably expressed gene by NormFinder (Figure 2A)
and geNorm (Figure 2B), no further patterns of agreement
in rank ordering of the expression profiles were identified.
ATIC was identified as the most stably expressed gene by
NormFinder (Figure 2A) and Bestkeeper© (Figure 2C), and
the 6th most stably expressed gene by geNorm.
Table 1: A list of the gene annotations, functions, primer and probe sequences, and qPCR metrics for the 12 new reference genes, and 
glyceraldehyde 3-phosphate dehydrogenase
Gene Name Gene Function Gene 
Symbol
Accession 
Number 
[GenBank]
Forward(F) and 
Reverse(R) Primers
Probe 
Sequence
Average 
Standard 
Deviation of 
Triplicate
R2 PCR 
Efficiency
CG14980-PB Protein coding C7orf28B XM_536878 F-gcaggaagggattctccag
R-ggtccagtaagaaatcttccataa
gccaggaa 19.8 0.986 104.3
Glyceraldehyde-
3-phosphate 
dehydrogenase
Enzyme in the glycolysis/
gluconeogenesis 
pathway
GAPDH NM_001003142 F-ctggggctcacttgaaagg
R-caaacatgggggcatcag
ctgctcct 20.3 0.991 101.1
Gu binding 
protein
Nuclear receptor in 
transcriptional co-
regulation
PIAS1 XM_535524 F-ggagacaatcagcattataacacct
R-tgatcatctgacactgctgct
ggctgctg 16.9 0.990 99.6
HIRA interacting 
protein 5 
isoform 2
Histone-interaction-
DNA packaging
HIRP5 XM_850340 F-aattcagaacatgctgcaatttta
R-tgattcatcatccataacctgttc
aggtggag 8.6 0.998 96.9
Hematopoietic 
stem/progenitor 
cells 176
Transport protein 
particle involved in 
endoplasmic reticulum 
to Golgi vesicle 
transport
TRAPPC2L XM_844929 F-gatgatccaggtgtgctgag
R-caatacggttatgtcaacagcact
ctggagga 25.2 0.993 97.2
5-
aminoimidazole-
4-carboxamide 
ribonucleotide 
formyltransferas
e/IMP 
cyclohydrolase
Purine biosynthesis ATIC XM_858011 F-cgctgcctctttcaaacat
R-tttggcctcatcttcactgag
cagcaggt 13.4 0.991 97.7
Mitogen-
activated 
protein kinase 6
Phosphorylates 
microtubule-associated 
protein 2 (MAP2)
MAPK6 XM_858091 F-tcttcttgggatagccagtttg
R-cctcacctcacaacaaaactgat
ggtggtgg 14.9 0.992 97.6
Mitochondrial 
28S ribosomal 
protein S25
Mitochondrial ribosomal 
subunit protein synthesis
MRPS25 XM_533729 F-tgaaggtcatgacggtgaac
R-tggatctgaggtatgttgaaaaac
gccaggaa 14.6 1.000 95.5
Cytoplasmic 
protein NCK2
Regulates cell 
proliferation
NCK2 XM_538440 F-cagacgctctacccgttca
R-gtctcgcccttctcgaagtt
aggaggag 28.7 0.975 96.7
ORM1-like 2 Protein folding in the 
endoplasmic reticulum
ORMDL2 XM_843143 F-atggactacgggctccaat
R-ctggccaggaggtagagtaca
ctcctccc 28.2 0.996 103.1
Phosphatidylseri
ne synthase I
Membrane bound 
protein that catalyses 
the replacement of 
phospholipids by L-
serine
PTDSS1 XM_849686 F-actcagaatgcgacgatgg
R-tcagaaccttttgaacctttcg
ctggtctc 15.3 0.996 100.9
Mitochondrial 
ribosomal 
protein S7
Mitochondrial protein 
synthesis
MRPS7 XM_846915 F-agtgcagggagaagaagcac
R-cagcagctcgtgtgacaact
ggatgctg 12.1 0.998 100.8
Transketolase Enzyme in pentose 
phosphate pathway
TKT XM_533792 F-caacttctgtggctcccact
R-ccagatcttccagagccatc
tggggaag 11.8 0.993 103.4
Table 2: Correlation coefficients for the rank ordering of gene stability by different reference gene analysis methods
Tissue Method NormFinder GeNorm
Cartilage GeNorm 0.462
BestKeeper 0.515 0.721
Cruciate GeNorm 0.835
BestKeeper 0.915 0.794
Synovium GeNorm 0.833
BestKeeper 0.745 0.579
Fat Pad GeNorm 0.907
BestKeeper 0.867 0.939
Bone GeNorm 0.710
BestKeeper 0.382 0.475Page 3 of 10
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Rank ordering between NormFinder and geNorm agreed
on the seven most stably expressed (C7orf28B, MRPS25,
PIAS1, PTDSS1, ATIC, MRPS7 and HIRP5) genes but not
their order, and the least stably expressed gene (NCK2).
Bestkeeper© (Figure 2C) and NormFinder (Figure 2A)
agreed on the most stably expressed gene (C7orf28B).
Comparison of reference gene performance in all tissues
Using the reference gene stability value (M) of 0.40 as the
determinant of stable expression [6], MRPS7 was stably
expressed in all five tissues, and HIRP5 was found to be
stably expressed in four tissues (Figure 2B). GAPDH was
found to be unstable in all of the tissues evaluated, which
is consistent with the findings of a previous study of refer-
ence genes in these tissues [17]. Comparison of gene sta-
bility (M) and pairwise stability (V) values with a previous
study of commonly used reference genes using similar tis-
sues further illustrates how optimal reference gene stabil-
ities, as assessed by geNorm, can be achieved using the
new reference genes rather than the commonly used refer-
ence genes (Table 3).
No single reference gene was consistently identified as
being the most stably expressed by NormFinder, geNorm
or Bestkeeper© across most tissues. There was not consist-
ent agreement in the rank ordering, or the selection of the
optimal candidates by the different methods, although
Reference gene stability measures as determined by: 2AFigure 2
Reference gene stability measures as determined by: 2A. The NormFinder Algorithm (with a lower value indicating increased 
reference gene stability). 2B. The geNorm algorithm (with a stability measure [M value] <0.4 indication appropriate reference 
gene stability). 2C. The Bestkeeper algorithm (with a higher value indicating increased reference gene stability). Please note 
that as only the top 10 genes (as ranked by the NormFinder algorithm) are selected for analysis, thus there are not necessarily 
data points for each gene corresponding to each tissue.Page 4 of 10
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stable gene. For example Bestkeeper© and NormFinder
always identified the same gene as being most stably
expressed. When looking at rank order across all three ref-
erence gene stability programs, fat pad showed the highest
correlation between methods, followed by cruciate liga-
ment, cartilage, bone and synovium as the least consistent
(Table 2).
When the data for all tissues was compared together (Fig-
ure 2A, B, C), a much clearer pattern of reference gene sta-
bility was observed. The stability metrics of the reference
genes in different tissues show similar patterns across all
three methods. MRPS7 demonstrates the most consistent
metric (low geNorm M value, low NormFinder value and
high Bestkeeper© correlation), with HIRP5 and ATIC dem-
onstrating a similarly consistent stability across all tissues.
This is supported by the finding that MRPS7 was consist-
ently identified as being stably expressed in all tissues by
geNorm (MRPS7), as well as being ranked as one of the
two most stable reference genes in four of the five tissues
by geNorm (cartilage, fat, bone and synovium), and in
three of the five tissues using NormFinder and Bestkeeper©
(cartilage, ligament and fat).
Comparison genes identified by different methods
Identification of new reference genes using RT-qPCR
methodology for gene normalisation was not successful at
identifying new reference genes with increased stability.
NCK2 was determined to be the least stably expressed
gene in synovium and fat pad, and one of the four least
stably expressed genes in cruciate ligament and cartilage.
TRAPPC2L was not identified as being stably expressed in
any tissue using the geNorm algorithm, and was not
ranked higher than the 8th most stably expressed gene in
any tissue using the NormFinder algorithm.
Discussion
A number of different strategies have been employed to
filter microarray data to identify new reference genes, such
as selection on the co-efficient variation and level of
expression [11], fold changes of expression [14,16], or
integrative correlations [15]. We used a combination of
filtering on statistical significance, fold change and coeffi-
cient of variation (percentage standard deviation) to nar-
row the potential number of reference genes.
Furthermore, these criteria were applied to three different
experiments, using two different data sets, to identify
genes which were more likely to have generic stability
across multiple tissues for diseases. Genes were finally fil-
tered on the basis of defined annotation and level of
expression. In retrospect, genes should also have been
selected on the basis of single transcript expression (i.e.
the absence of splice variants). Although the two most sta-
bly expressed genes (MRPS7 and HIRP5) currently have
no splice variants reported, the absence of splice variants
did not necessarily confer reference gene stability across
multiple tissues (as demonstrated by GAPDH and
MRPS25, genes which do not have splice variants anno-
tated and were not the most stably expressed) but should
be taken into account when selecting new reference genes,
as another potential indicator of instability. Our filtering
method was straightforward, quickly performed and eas-
ily completed by any person without a full understanding
of microarray data set handling, and as such could be
applied to publicly available microarray data sets for a
given experiment or disease.
Variability in the expression of commonly used reference
genes has been recognised on the analysis of cell culture
experiments [18] and clinical tissue specimens [19]. The
selection of reference genes upon their stability as deter-
mined by the mathematical assessment of their expression
values is a widely accepted technique [6,12-15,20,21]. We
identified one gene which showed stable expression
Table 3: Comparison of M and V values generated in this study when compared to a previous study evaluating similar tissues
Current Study Ayers (2006) Study [17]
Tissues Reference 
Genes
M (Gene 
Stability) Value
V (Pairwise 
Stability) Value
Reference 
Genes
M (Gene 
Stability) Value
V (Pairwise 
Stability) Value
Articular MRPS7 0.37 0.122 RPL13A 0.57 0.31
Cartilage MRPS25 SDHA
Synovium MRPS7 0.2 0.091 N/A N/A N/A
ATIC
Cruciate HIRP5 0.2 0.093 B2M 0.59 0.27
Ligament C7orf28B TBP
Fad Pad C7orf28B 0.23 0.088 B2M 1.02 0.35
MRPS7 SDHA
Bone MRPS7 0.36 0.084 N/A N/A N/A
HIRP5Page 5 of 10
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a number of genes which demonstrated a relatively con-
sistent stability across the majority of tissue specimens
(HIRP5). One should bear in mind that the tissues evalu-
ated were from the same embryological origin (mesenchy-
mal tissue), and hence there may have been a tendency
towards identifying a reference gene which was stable in
all tissues, although this is not supported by reports of ref-
erence gene stability in different tissues [21]. Likewise, the
diseases compared in the microarray data sets were the
same as those affecting the tissue samples evaluated by
real-time RT-qPCR, which may further tend towards iden-
tifying reference genes whose stability was constant.
Therefore, although we identified one gene as being stably
expressed in all tissues, we would not advocate its use as a
reference gene in other tissues or diseases without assess-
ment of its stability in the samples to be evaluated
[6,16,21], as the utopia of a universal reference gene suit-
able for all studies probably does not exist on basis of the
published evidence to date.
Mitochondrial ribosomal protein S7 is involved in mito-
chondrial protein synthesis. The precise function of this
gene is unknown in eukaryotes, but the protein is thought
to be involved in organising the 3' domain of the 16 S
rRNA in the mitochondria of prokaryotes, and thus be
involved in the initiation of translation in mammalian
mitochondria [22]. Microarray data analysis indicated the
mitochondrial ribosomal protein S25 was also stably
expressed, although it was only stably expressed in two of
the four tissues analysed by RT-qPCR (cartilage and fat
pad). In a separate study, mitochondrial ribosomal pro-
tein L19 was one of six genes identified from microarray
data obtained from different tissues and cells, as a good
reference gene for real-time RT-qPCR experiments, when
compared to conventional reference genes for mammary
tumour expression profiling [16]. Mitochondrial ribos-
omal gene expression appears to show greater stability
across different tissues and thus may be less affected by tis-
sue type or disease status, and better potential candidate
reference genes for other real-time RT-qPCR experiments.
Comparing the results of this study to a similar previous
study of commonly used reference genes in multiple artic-
ular tissues demonstrates the increased stability of the
"new" reference genes (Table 3) [17]. The selection of can-
didate reference genes from microarray data identified
new genes which were more stably expressed and is con-
sistent with the general outcome of previous studies using
this methodology [11,14-16]. The normalisation of
microarray data by geometric mean of three reference
genes [6] did not identify genes (NCK2 or TRAPPC2L)
with appropriate stability to be suitable for use as refer-
ence genes. The instability of these genes may be reflected,
in part, by the greater variation identified in the triplicate
repeats of each assay when compared to more genes deter-
mined as being more stably expressed such as HIRP5 or
MRPS7. The less stable expression of the three conven-
tional reference genes (GAPDH, RPL13A and SDHA)
probably resulted in the selection of similarly "unstably"
expressed reference genes from microarray data, and thus
accounted for this being a futile method of trying to select
reference genes, which agrees with the evaluation of these
types of methodologies for the accurate normalisation of
microarray data [23]. These genes were selected on the
basis of a preliminary study of reference gene stability in
canine OA tissues [24], however subsequent work evalu-
ating greater sample numbers has determined that one of
these genes (SHDA) demonstrates differential expression
in OA cartilage [25] and thus its use may have further pre-
disposed to the selection of genes which were not stably
expressed. Furthermore, the conventionally used refer-
ence gene we evaluated (GAPDH) did not show accepta-
ble stable expression in any of the tissues we analysed.
We used three different methods of ranking reference gene
stability in each experiment. Correlation co-efficient
could be generated to compare methods and quantify the
agreement of the rank ordering of different methods. Pre-
vious studies have demonstrated that the generation of
rank orders can be very similar between different methods
[14], but this is not always the case [11]. The best correla-
tion in rank ordering was observed between geNorm and
Bestkeeper©, across all the tissues which is unsurprising as
both are generated by pairwise comparisons (although
geNorm uses transformed data, whereas Bestkeeper© uses
threshold cycle values), although Bestkeeper© and
NormFinder always identified the same gene as being
most stably expressed. The rank order of reference gene
stability was identified most consistently for fat pad, fol-
lowed by cruciate ligament, cartilage, bone and least con-
sistently for synovium.
The advantage of using a model based stability assessment
is that rank ordering can be changed if co-regulated genes
are included in the stability assessment procedure, as pair-
wise assessments will determine an increase in stability
between these methods [11]. As we identified a number of
new reference genes which have very little functional
information associated with their annotation, we checked
for co-regulation between the most stably expressed genes
by removing one of the highest ranked genes (as deter-
mined by pairwise comparisons) alternately, and re-
assessing the rank ordering of reference genes stabilities.
No major changes in rank ordering or reference gene sta-
bility were observed when this was performed. However,
it should be noted that other factors besides gene expres-
sion pathway similarities can contribute to co-regulation.
Yu et al. (2003) identified that genes targeted by similar
transcription factors have complex relationships acrossPage 6 of 10
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determining reference gene stability did not necessarily
agree on rank order, but were good at determining both
the most and least stably expressed genes, regardless of
method. The top two most stably expressed genes ana-
lysed by geNorm for each tissue were then used to study
cytokine gene expression in canine osteoarthritis [27].
Conclusion
The use of microarray data for the selection of reference
genes allowed the identification of multiple genes dem-
onstrating greater stability than a conventional reference
gene in multiple tissues. Mitochondrial ribosomal protein
S7 is suitable for use in all the experimental conditions we
analysed, and is suitable for investigation in other experi-
ments. Different methods of assessment of gene stability
do not always show correlation between the rank order of
gene expression stability, but they do generally agree on
which genes are suitable for use to normalise gene expres-
sion experiments.
Methods
Microarray data
Expression profiling data from 10 hip articular cartilage
samples (5 control, 5 from osteoarthritic [OA] joints) and
16 cranial cruciate ligament (CCL) samples (4 normal
low-risk of rupture, 7 normal high-risk of rupture, and 5
ruptured ligament from OA joints) were generated from a
custom designed 44 k transcript canine whole genome 60
mer oligonucleotide microarray [28]. Raw data was nor-
malised by two methods; locally weighted scatterplot
smoothing (LOWESS), or using the geometric mean of 3
conventional reference genes arbitrarily selected (glyceral-
dehyde-3-phosphate dehydrogenase [GAPDH], ribos-
omal protein L13a [RPL13A], succinate dehydrogenase
flavoprotein subunit A [SDHA]). Expression quantifica-
tion was exported into an Excel Datasheet (Microsoft
Excel 2003), and the data compared in three separate
experiments as follows;
1) Normal hip articular cartilage was compared to OA car-
tilage,
2) Normal CCL (high-risk of rupture) was compared to
normal CCL (low-risk of rupture),
3) Normal CCL (high risk of rupture) was compared to
ruptured CCL
Selection of reference gene candidates
The stepwise procedure for identifying candidate refer-
ence genes is illustrated in Figure 1. Data for each refer-
ence gene candidate was compared in each experiment by
calculating the fold change in mean expression level
(between the two comparison groups), student's t-tests
and percentage standard deviation (co-efficient of varia-
tion). To identify the most stably expressed genes across
each of the experiments, the prospective reference genes
were then selected using the following the criteria;
1. Student's t-test P value > 0.5 (in all experiments).
2. Ratio of expression between the two groups compared
in each experiment <1.5 (in all experiments).
3. Standard deviation of the mean expression in each
experimental group being <30% (in all experiments).
The data sets were reduced to 420 transcripts (LOWESS
normalised) and 13 transcripts (reference gene normalisa-
tion). To further refine and filter the new reference gene
list, data was ordered on the average signal intensity and;
4. The probe sequences used from the microarray experi-
ments were entered into the NCBI BLAST® database [29] to
confirm the gene identity,
5. Gene function was determined [29] and the associated
gene information checked to ensure no known involve-
ment in OA.
Complete filtering reduced the data set to 12 genes, of
which 10 were selected from the LOWESS normalised
data, (CG14980-PB [C7orf28B], Gu binding protein
[PIAS1], HIRA interacting protein 5 isoform 2 [HIRP5], 5-
aminoimidazole-4-carboxamide ribonucleotide formyl-
transferase/IMP cyclohydrolase [ATIC], Mitogen-activated
protein kinase 6 [MAPK6], Mitochondrial 28S ribosomal
protein S25 [MRPS25], ORM1-like 2 [ORMDL2], Phos-
phatidylserine synthase 1 [PTDSS1], Mitochondrial ribos-
omal protein S7 [MRPS7] and Transketolase [TKT]), and
2 were selected from the reference gene normalised data
(Hematopoietic stem/progenitor cells 176 [TRAPPC2L]
and Cytoplasmic protein NCK2 [NCK2]). Glyceralde-
hyde-3-phosphate dehydrogenase [GAPDH] was also
selected as it is a commonly used reference. The sequence
details and putative functions (determined by reference to
the human transcripts [29]) are listed in Table 1.  
Sample collection and storage
A separate set of samples were collected for the analysis of
the new reference genes. Infrapatellar fat (n = 5), ruptured
cranial cruciate ligament (n = 5), femoral head articular
cartilage (n = 5), ulnar subchondral bone (n = 5) and syn-
ovial membrane (n = 5) were obtained from dogs with
clinical OA secondary to naturally occurring joint disease.
In each case the samples were obtained as part of the
standard surgical treatment for the disease in question
(total hip replacement, cranial cruciate ligament rupture
surgery or fragmented coronoid process removal). Con-Page 7 of 10
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fat pad (n = 5), cranial cruciate ligament (n = 5), synovial
membrane (n = 5), hip articular cartilage (n = 5) and ulnar
bone (n = 5) of dogs euthanized for reasons other than,
and with no evidence of, joint disease. Following the col-
lection of the tissue, the samples were weighed and imme-
diately stored in RNAlater™ (Qiagen Inc, Crawley, UK),
according to the manufacturer's instructions, until extrac-
tion.
RNA extraction
For all of the tissue samples total RNA was extracted using
a phenol/guanidine hydrochloride reagent (Trizol, Invit-
rogen Ltd, UK) with a chloroform extraction and ethanol
precipitation, as previously described [30]. An on column
DNA digestion step was included (RNase-Free DNase Set,
Qiagen Ltd, Crawley, UK). Final elution of the total RNA
was performed using 30 μl of RNase free water, and
repeated to maximize the amount of RNA eluted. Total
RNA samples were stored at -80°C until use. The concen-
tration of total RNA representing each sample was quanti-
fied by using a NanoDrop® ND – 1000 UV/Visible
Spectrophotometer (NanoDrop Technologies Ltd, Utah,
USA).
cDNA synthesis
Reverse transcription was performed using Superscript II
reverse transcriptase (Invitrogen, Dorset, UK) according to
the manufacturers instructions [31]. Initially 200 μg (10
μl) total RNA was pre-incubated with 0.5 μg (1 μl) oligo-
dT12–18 (Invitrogen, Paisley, UK) and 10 mM (1 μl) dNTP
mix (Invitrogen, Paisley, UK) at 65° for 5 minutes. After
Figure 1
Microarray data normalised by two different methods was filtered to identify new reference genes using statistical significance, 
fold changes in expression between experimental groups, the co-efficient of variation and ontological evaluationPage 8 of 10
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250 mM Tris-HCI (pH 8.3), 375 mM KC1, 15 mM
MgCl2), 2 μl of 0.1 M DTT and 40 units (1 μl) of RNAse
(Promega, Southhampton, UK) were added to each sam-
ple and the samples incubated for 2 minutes at 42°C, fol-
lowed by the addition of 200 units (1 μl) of Superscript II
reverse transcriptase (Invitrogen, Doreset, UK) and incu-
bated for 50 minutes. Reverse transcriptase activity was
terminated by incubation at 70°C for 15 minutes, and
samples stored at -80°C until use.
Real-time reverse transcriptase quantitative PCR assay 
design
Transcript sequences were obtained from the National
Centre for Biotechnology Information [29] and were cross
referenced to the Ensembl canine genome database [32].
Primer and probe sequences were then designed for each
of the reference genes by using the Universal Probe Library
Assay Design Centre (Roche Diagnostics Ltd; [33]) BLAST
searches were performed for all primer sequences to con-
firm gene specificity, and electrophoresis of the PCR reac-
tion mixture confirmed a single product of the
appropriate length in all cases. Primers were synthesized
by Metabion International AG (Martinsried, Germany),
and probes were synthesized by Roche Diagnostics
(Lewes, UK) using locked nucleic acid with 5'-end reporter
dye fluorescein (FAM (6-carboxy fluorescene)) and 3'-end
dark quencher dye.
Real-time RT-qPCR assays were performed in triplicate
using the LightCycler® 480 (Roche Diagnostics; Lewes,
UK) in 384 well format, with three no template controls
used for each assay. The reaction volume in each well con-
sisted of 5 μL LightCycler® 480 Probes Master 2 × concen-
tration (Roche Diagnostics) (containing FastStart Taq
DNA Polymerase, reaction buffer, dNTP mix (with dUTP)
and 6.4 mM MgCl2), 0.7 μL of LightCycler® 480 Probes
Master H2O (Roche Diagnostics), 0.1 μL of 20 μM forward
primer, 0.1 μL of 20 μM reverse primer, 0.1 μL of 10 μM
fluorescently-labelled probe and either 4 μL of sample
cDNA, diluted template, or 4 μL of LightCycler® 480
Probes Master H2O. The standard amplification condi-
tions consisted of 1 cycle at 95°C for 5 minutes, followed
by 50 cycles of 95°C for 15 seconds and 60°C for 30 sec-
onds. Real-time RT-qPCR data was then analysed by using
LightCycler® 480 Basic Software (Roche Diagnostics;
Lewes, UK). Standard curves were generated for each ref-
erence gene by employing cDNA or template oligonucle-
otides [34], the parameters of which are listed in Table 1.
All samples were checked for absence of genomic DNA
contamination using a canine genome specific RT-qPCR
assay, previously described [25]. The assays were deemed
to be reproducible, as determined by the average standard
deviation of the triplicate repeats of each assay being less
than 30% (Table 1).
Reference gene stability analysis
Real-time RT-qPCR data was exported into an Excel
datasheet (Microsoft Excel 2003) and analysed using three
separate reference gene stability analysis software pack-
ages; geNorm [6],  Bestkeeper©[9] and NormFinder [11].
Each of these methods generates a measure of reference
gene stability, which can be used to rank the reference
genes in order of stability. GeNorm generates a stability
measure (the M value) for each gene which is arbitrarily
suggested to be lower than 0.4 (with a lower value indicat-
ing increased gene stability across samples), and a pair-
wise stability measure to determine the benefit of adding
extra reference genes for the normalisation process, with
again a lower value indicating greater stability of the nor-
malised genes, and a lower value indicating greater stabil-
ity with an arbitrary cut off value of lower than 0.15
indicating acceptable stability of the reference gene com-
bination [6]. NormFinder generates a stability measure of
which a lower value indicates increased stability in gene
expression. By using a model-based approach,
NormFinder groups samples to allow for a direct estima-
tion of expression variation, compared to the pairwise
comparison approach that ranks genes according to the
similarity of their expression profiles. Therefore, taking a
sample set which consists of two sample subgroups where
all of the candidates but one show little difference
between the groups, the one candidate which shows no
difference will have the smallest stability value across all
candidates and be the most stably expressed gene. Best-
keeper© generates a pairwise correlation co-efficient
between each gene and the Bestkeeper© index (the geomet-
ric mean of the threshold cycle values of all the reference
genes grouped together). Stability measures for combined
(normal and diseased) samples were recorded, as ulti-
mately it is these measures which would be used to deter-
mine which genes were suitable for normalising
expression data from genes of interest in a particular dis-
ease (osteoarthritis) in practice.
Bestkeeper© can only be used to analyse a maximum of 10
housekeeping genes so the three genes least stably
expressed (as determined by NormFinder) were excluded
from Bestkeeper© analysis. The stability values for each
gene, as determined by each method of analysis, are illus-
trated in Figure 2A, B, and 2C. Statistical tests were per-
formed using a statistical software package (Minitab
V14.1; Minitab Ltd.; Coventry, UK). Spearman rank corre-
lation coefficients were then calculated using the ranking
order of genes to compare the relationship of the relative
ordering of genes by different methods of analysis (Table
2). Finally, the stability parameters of the new reference
genes were compared to those generated for commonly
used reference genes in a similar study of canine OA tis-
sues [17] (Table 3).Page 9 of 10
(page number not for citation purposes)
BMC Molecular Biology 2007, 8:62 http://www.biomedcentral.com/1471-2199/8/62Authors' contributions
DNC and LM carried out the microarray data analysis. LM
and FS carried out the assay design. DNC, LM and FS per-
formed the molecular genetic studies and DNC performed
the statistical analysis. DNC and PJRD conceived the
study, its design and coordination, and drafted the manu-
script with LM.
Acknowledgements
LM was self funded, DNC was funded by the Biotechnology and Biological 
Sciences Research Council, FS was funded by the University of Manchester, 
and PJD was funded by the Higher Education Funding Council of England. 
The study was funded in part by a grant from the PetPlan charitable trust, 
UK, and in part by a project grant from the University of Manchester. The 
manuscript preparation was funded by the University of Manchester. Nei-
ther funding body had any role in the study design; in the collection, analysis, 
and interpretation of data; in the writing of the manuscript; or the decision 
to submit the manuscript for publication.
References
1. Bustin SA, Nolan T: Pitfalls of Quantitative Real-Time Reverse-
Transcription Polymerase Chain Reaction.  J Biomol Tech 2004,
15:155-166.
2. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E,
Mueller O, Schroeder A, Auffray C: Towards standardization of
RNA quality assessment using user-independent classifiers
of microcapillary electrophoresis traces.  Nucleic Acids Res 2005,
33:e56.
3. Bustin SA: Quantification of mRNA using real-time reverse
transcription PCR (RT-PCR): trends and problems.  J Mol
Endocrinol 2002, 29:23-39.
4. Lekanne Deprez RH, Fijnvandraat AC, Ruijter JM, Moorman AFM:
Sensitivity and accuracy of quantitative real-time polymer-
ase chain reaction using SYBR green I depends on cDNA syn-
thesis conditions.  Anal Biochem 2002, 307:63-69.
5. Huggett J, Dheda K, Bustin S, Zumla A: Real-time RT-PCR nor-
malisation; strategies and considerations.  Genes Immun 2005,
6:279-284.
6. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De
Paepe A, Speleman F: Accurate normalization of real-time
quantitative RT-PCR data by geometric averaging of multi-
ple internal control genes.  Genome Biology 2002, 3:0034.1-
0034.11.
7. Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, Zumla A: Val-
idation of housekeeping genes for normalizing RNA expres-
sion in real-time PCR.  Biotechniques 2004, 37:112-119.
8. Akilesh S, Shaffer DJ, Roopenian D: Customized Molecular Phe-
notyping by Quantitative Gene Expression and Pattern Rec-
ognition Analysis.  Genome Res 2003, 13:1719-1727.
9. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP: Determination of
stable housekeeping genes, differentially regulated target
genes and sample integrity: BestKeeper--Excel-based tool
using pair-wise correlations.  Biotechnology Letters 2004,
26:509-515.
10. Haller F, Kulle B, Schwager S, Gunawan B, von Heydebreck A, Sult-
mann H, Fuzesi L: Equivalence test in quantitative reverse tran-
scription polymerase chain reaction: confirmation of
reference genes suitable for normalization.  Anal Biochem 2004,
335:1-9.
11. Andersen CL, Jensen JL, Orntoft TF: Normalization of Real-Time
Quantitative Reverse Transcription-PCR Data: A Model-
Based Variance Estimation Approach to Identify Genes
Suited for Normalization, Applied to Bladder and Colon
Cancer Data Sets.  Cancer Res 2004, 64:5245-5250.
12. Radonic A, Thulke S, Bae HG, Muller MA, Siegert W, Nitsche A: Ref-
erence gene selection for quantitative real-time PCR analy-
sis in virus infected cells: SARS corona virus, Yellow fever
virus, Human Herpesvirus-6, Camelpox virus and Cytomeg-
alovirus infections.  Virology Journal 2005, 2:7.
13. Spinsanti G, Panti C, Lazzeri E, Marsili L, Casini S, Frati F, Fossi C:
Selection of reference genes for quantitative RT-PCR stud-
ies in striped dolphin (Stenella coeruleoalba) skin biopsies.
BMC Molecular Biology 2006, 7:32.
14. de Brouwer AP, van Bokhoven H, Kremer H: Comparison of 12
reference genes for normalization of gene expression levels
in Epstein-Barr virus-transformed lymphoblastoid cell lines
and fibroblasts.  Molecular Diagnosis and Therapeutics 2006,
10(3):197-204.
15. Saviozzi S, Cordero F, Lo M, Novello S, Giorgio VS, Calogero R:
Selection of suitable reference genes for accurate normali-
zation of gene expression profile studies in non-small cell
lung cancer.  BMC Cancer 2006, 6:200.
16. Szabo A, Perou CM, Karaca M, Perreard L, Quackenbush JF, Bernard
PS: Statistical modeling for selecting housekeeper genes.
Genome Biology 2004, 5:R59.
17. Ayers D, Clements DN, Salway F, Day PJR: Expression stability of
commonly used Control Genes in Canine Articular Connec-
tive Tissues.  Submitted for publication 2006.
18. Gorzelniak K, Janke J, Engeli S, Sharma AM: Validation of endog-
enous controls for gene expression studies in human adi-
pocytes and preadipocytes.  Horm Metab Res 2001, 33:625-627.
19. Matyas JR, Huang D, Adams ME: A comparison of various "house-
keeping" probes for northern analysis of normal and oste-
oarthritic articular cartilage RNA.  Connect Tissue Res 1999,
40:163-172.
20. Bogaert L, Van Poucke M, De Baere C, Peelman L, Gasthuys F, Mar-
tens A: Selection of a set of reliable reference genes for quan-
titative real-time PCR in normal equine skin and in equine
sarcoids.  BMC Biotechnology 2006, 6:24.
21. Brinkhof B, Spee B, Rothuizen J, Penning LC: Development and
evaluation of canine reference genes for accurate quantifica-
tion of gene expression.  Anal Biochem 2006, 356:36-43.
22. Cavdar Koc E, Blackburn K, Burkhart W, Spremulli LL: Identifica-
tion of a Mammalian Mitochondrial Homolog of Ribosomal
Protein S7.  Biochem Biophys Res Commun 1999, 266:141-146.
23. Listgarten J, Graham K, Damaraju S, Cass C, Mackey J, Zanke B: Clin-
ically validated benchmarking of normalisation techniques
for two-colour oligonucleotide spotted microarray slides.
Applied Bioinformatics 2003, 2:219-228.
24. Ayers D, Clements D, Salway F, Day P: Expression stability of
commonly used reference genes in canine articular connec-
tive tissues.  BMC Veterinary Research 2007, 3:7.
25. Clements DN, Carter SD, Innes JF, Ollier WE, Day PJ: Analysis of
normal and osteoarthritic canine cartilage mRNA expres-
sion by quantitative-PCR.  Arthritis Res Ther 2006, 8:R158.
26. Yu H, Luscombe NM, Qian J, Gerstein M: Genomic analysis of
gene expression relationships in transcriptional regulatory
networks.  Trends Genet 2003, 19:422-427.
27. Maccoux LJ, Salway F, Day PJR, Clements DN: Expression profiling
of select cytokines in canine osteoarthritis tissues.  Vet Immu-
nol Immunopathol 2007, 118(1-2):59-67.
28. Jones P, Jones C, Fretwell N, Martin A, Soloviev M: Design and pro-
duction of a whole genome dog oligonucleotide microarray.
Advances in Canine and Feline Genomics 2004.
29. Information NCB: National Centre for Biotechnology Informa-
tion.  2007 [http://www.ncbi.nlm.nih.gov].
30. Clements DN, Vaughan-Thomas A, Peansukmanee S, Carter SD,
Innes JF, Ollier WER, Clegg PD: Assessment of the use of RNA
quality metrics for the screening of normal and pathological
canine articular cartilage samples.  Am J Vet Res 2006,
67:1438-1444.
31. Invitrogen: Invitrogen.  2006 [http://www.invitrogen.com].
32. Ensembl: Ensembl.  2007 [http://www.ensembl.org].
33. Ltd RD: Roche Diagnostics Ltd.  2007 [http://www.roche-applied-
science.com].
34. Mohammadi M, Day PJR: Oligonucleotides used as template cal-
ibrators for general application in quantitative polymerase
chain reaction.  Anal Biochem 2004, 335:299-304.Page 10 of 10
(page number not for citation purposes)
